Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank8
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Latest
$-33.23M
↓ 326% vs avg
Percentile
P8
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-7.79M
Historical baseline
PeriodValueYoY Change
TTM$-33.23M-199.2%
2024$33.50M+901.6%
2023$-4.18M+0.3%
2022$-4.19M-73.8%
2021$-2.41M+96.4%
2020$-67.18M-45708.4%
2019$147291.00+168.2%
2018$54928.00+202.4%
2017$-53640.00+86.3%
2016$-391556.00-